activins has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brinkoetter, M; Magkos, F; Mantzoros, CS; Vamvini, M | 1 |
| Tsuchida, K | 1 |
1 review(s) available for activins and Metabolic Diseases
| Article | Year |
|---|---|
Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders.
Topics: Activins; Animals; Autoimmune Diseases of the Nervous System; Drug Delivery Systems; Endocrine System Diseases; Humans; Metabolic Diseases; Myostatin; Transforming Growth Factor beta | 2004 |
1 trial(s) available for activins and Metabolic Diseases
| Article | Year |
|---|---|
Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women.
Topics: Activins; Adipose Tissue; Adult; Body Composition; Body Weight; Double-Blind Method; Down-Regulation; Female; Follistatin; Humans; Leptin; Metabolic Diseases; Myostatin; Placebos; Signal Transduction; Thinness; Young Adult | 2011 |